Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma
P. Argani et al., Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma, CANCER RES, 61(11), 2001, pp. 4320-4324
Serial analysis of gene expression (SAGE) can be used to quantify gene expr
ession in human tissues. Comparison of gene expression levels in neoplastic
tissues with those seen in nonneoplastic tissues can, in turn, identify no
vel tumor markers. Such markers are urgently needed for highly lethal cance
rs like pancreatic adenocarcinoma, which typically presents at an incurable
, advanced stage. The results of SAGE analyses of a large number of neoplas
tic and nonneoplastic tissues are now available online, facilitating the ra
pid identification of novel tumor markers. We searched an online SAGE datab
ase to identify genes preferentially expressed in pancreatic cancers as com
pared with normal tissues. SAGE libraries derived from pancreatic adenocarc
inomas were compared with SAGE libraries derived from nonneoplastic tissues
, Three promising tags mere identified, Two of these tags corresponded to g
enes (lipocalin and trefoil factor 2) previously shown to be overexpressed
in pancreatic carcinoma, whereas the third tag corresponded to prostate ste
m cell antigen (PSCA), a recently discovered gene thought to be largely res
tricted to prostatic basal cells and prostatic adenocarcinomas, PSCA was ex
pressed in four of the six pancreatic cancer SAGE libraries, but not in the
libraries derived from normal pancreatic duetal cells, We confirmed the ov
erexpression of the PSCA mRNA transcript in 14 of 19 pancreatic cancer cell
Lines by reverse transcription-PCR, and using immunohistochemistry, we dem
onstrated PSCA protein overexpression in 36 of 60 (60%) primary pancreatic
adenocarcinomas. In 59 of 60 cases, the adjacent nonneoplastic pancreas did
not label for PSCA, PSCA is a novel tumor marker for pancreatic carcinoma
that has potential diagnostic and therapeutic implications, These results e
stablish the validity of analyses of SAGE databases to identify novel tumor
markers.